Chinese medicinal composition for treating leukemia

Abstract

The invention discloses a Chinese medicinal composition for treating leukemia. The Chinese medicinal composition is prepared from Chinese herbal medicines in part by weight: 60 to 150 parts of glossy privet fruit, 20 to 80 parts of Chinese magnoliavine fruit, 60 to 150 parts of reed rhizome, 20 to 80 parts of common selfheal fruit, 20 to 80 parts of cinnamomvine, 20 to 80 parts of malaytea scurfpea fruit, 60 to150 parts of desertliving cistanche, 20 to 80 parts of eucommia bark, 20 to 80 parts of eclipta alba, 20 to 80 parts of mulberry, 20 to 80 parts of white paeony root, 20 to 80 parts of red paeony root, 60 to 150 parts of anemarrhena asphodeloides, 20 to 80 parts of sweet wormwood herb, 20 to 80 parts of dried rehmannia root, 20 to 80 parts of prepared rehmannia root, 20 to 80 parts of fragrant solomonseal rhizome, 100 to 200 parts of Chinese angelica, 20 to 80 parts of astragalus, 5 to 35 parts of licorice root, 20 to 80 parts of honeysuckle flower, 20 to 80 parts of peach seed, 20 to 80 parts of Indian buead, 20 to 80 parts of largehead atractylodes rhizome, 20 to 80 parts of red date, 20 to 80 parts of medlar, 20 to 80 parts of small red beans, 20 to 80 parts of swordlike atractylodes rhizome, 100 to 200 parts of gloss ganoderma, 20 to 80 parts of scrophularia, 20 to 80 parts of rhubarb, 9 to 20 parts of Chinese caterpillar fungus, 50 to 120 parts of ginseng, 60 to 150 parts of American ginseng, 9 to 20 parts of saffron, 20 to 80 parts of bletilla striata, 20 to 80 parts of rhodiola rosea, 20 to 80 parts of notoginseng root, 20 to 80 parts of turtle shell, 20 to 80 parts of India mockstrawberry herb and 300 to 700 parts of deer medulla spinalis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating leukemia, in particular to a traditional Chinese medicine composition prepared from Chinese herbal medicines. Background technique [0002] Leukemia, commonly known as blood cancer, is a malignant disease that strongly destroys and damages hematopoietic stem cells and seriously endangers human health. With this disease, leukemia cells proliferate and accumulate in large numbers in bone marrow and other hematopoietic tissues, and infiltrate or destroy other organs and tissues, so that normal blood cells are inhibited. According to the development speed and natural course of leukemia cells, leukemia can be divided into two categories: acute and chronic. In acute leukemia, the cell differentiation stagnates at an earlier stage, and most of them are primitive cells and early immature cells. The disease develops rapidly and the natural course is only a few months, that is to s...

AI Technical Summary

Problems solved by technology

The vast number of medical workers are studying and looking for effective methods of treatment, but there is no effective medicine for curing leukemia